Is HHC legal in Turkey?

Legal status

HHC is not confirmed as a controlled substance in Turkey and this row is a deferral rather than a finding. The dossier searched the Turkish terms «hekzahidrokannabinol» and «HHC» and the transliterations hekzahidrokannabinol and HHC against the classification decisions made under article 19 of Law No. 2313 on the Control of Narcotic Substances, and confirmed no current entry. It rejected the near match «THC», because HHC is hydrogenated and not identical to THC. Hydrogenation removes the double bond that most schedule entries describe, which is precisely why the compound was brought to market, and Turkish law carries no general derivative clause that would follow it. What does follow it is the plant law. Article 3 of Law No. 2313 prohibits the preparation, import, export and sale of esrar in whatever form, and article 23 subjects all hemp growing to permission and places hemp derived medicinal, health and personal care products under Ministry of Health licensing with pharmacy only sale since Law No. 7557 of 21 July 2025.

Consequences if caught

Capital exposure: none. No article in this chain carries a capital or whole life route, and no per-substance threshold was verified for this row. If a classification decision names HHC, the ceiling is 30 years under article 188(1) of Penal Code No. 5237, the domestic conduct floor in article 188(3) is not less than ten years, and article 191(1) sets two to five years for possession for use with the five year deferral of 191(2) and at least a year of denetimli serbestlik under 191(3). If no decision names it, the Penal Code articles do not reach the molecule as such. The realistic exposure on this row is that commercial HHC products are hydrogenated from hemp extract and commonly contain residual delta-9-THC, which is scheduled, so the analysis taken under article 20 of Law No. 2313 can convert an unresolved row into a straightforward cannabis charge.

If prescribed or medical

There is no prescription route for HHC in Turkey. It has no medicinal authorisation, the dossier carried no prescription instrument for this row, and no per-substance medical route is asserted here. The pharmacy route created by article 23 of Law No. 2313 as amended in 2025 is for hemp derived products licensed and registered by the Ministry of Health, and whether any HHC product holds such a licence is for the TİTCK to state and is deferred. Retail availability in another market is not a Turkish authorisation.

Documentation

Do not treat an unconfirmed molecule as a cleared product, and note that this row is one where the answer has moved quickly elsewhere. A vape, flower or edible containing HHC is an unanalysed cannabis derived preparation at a Turkish border, its residual delta-9 content is a matter for the laboratory, and no retail label answers either question. Check the position again close to travel rather than relying on a status recorded at the date below. The search log was read in the dossier on 18 September 2026 and articles 3 and 23 were read from the consolidated statute on 20 September 2026.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Turkey’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.